|
|
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with HSV Gc x HSV gD x HSV gE
100 Translational Medicine associated with HSV Gc x HSV gD x HSV gE
0 Patents (Medical) associated with HSV Gc x HSV gD x HSV gE